Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Expression of p16(Ink4a) and p19(Arf) increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16(Ink4a) or p19(Arf) die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16(Ink4a) and p19(Arf). Inactivation of p16(Ink4a) in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19(Arf) inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16(Ink4a) is an effector and p19(Arf) an attenuator of senescence and ageing in these tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with this idea is the observation that interference with senescent cell accumulation in BubR1 progeroid mice delays several aging-associated disorders that these animals develop 4 , 5 .”
From Naturally occurring p16Ink4a-positive cells shorten healthy lifespan (2016) · cites this paper as [5]
In the citing paper
“In the absence of p16, the age-related deterioration of adipose tissue, skeletal muscle and eye was attenuated193.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Importantly, genetically preventing the accumulation of p19ARF, a tumour suppressor that modulates the stability of p53 by influencing MDM2-mediated destruction, did not result in similar prevention193, indicating that p16 was critical for these disorders.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Removal of SnCs delays several pathologies7–9 and increases healthy lifespan8.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [9]
In the citing paper
“Remarkably, treated mice of both BubR1H/H;INK-ATTAC lines had substantially delayed onset of lordokyphosis (a measure of sarcopenia onset in this model15) and cataracts compared to untreated mice (Fig. 2b, c).”
From Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (2011) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V., & Antoch, M. P. (2006) · Genes & Development · doi:10.1101/gad.1432206 · Cited by 1,188
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 1×
“Both p16 Ink4a and p19 Arf are effectors of senescence in cultured cell”
Backgroundp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1×
“Recent evidence in middle-aged p16 Ink4a knockout mice indicates that the age-induced expression of p16 Ink4a limits the proliferative and regenerative capacity of progenitor population”
Background
Cited by
Items 201–300 of 410
Sieben, C. J., Jeganathan, K. B., Nelson, G. G., Sturmlechner, I., Zhang, C., van Deursen, W. H., Bakker, B., Foijer, F., Li, H., Baker, D. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126863 · Cited by 30
“biweekly for cataracts and kyphosis as previously described (9).”
BackgroundMethodInfluentialSelf-citationJin, H., Zhang, Y., Liu, D., Wang, S. S., Ding, Q. J., Rastogi, P., Purvis, M., Wang, A., El-Hadi, S., Ren, C., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.09.013 · Cited by 34
“Despite its effectiveness in inhibiting neoplastic transformation(37) and, in the short-term, its benefits with respect to tissue regeneration,(32) it is detrimental in the long-term because it drives inflammation and age-related disease in multiple organs, including the kidney.(27,38,39) This may be due to both the c…”
BackgroundTumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 30
p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia
Radisky, D. C., Santisteban, M., Berman, H. K., Gauthier, M. L., Frost, M. H., Reynolds, C. A., Vierkant, R. A., Pankratz, V. S., Visscher, D. W., Tlsty, T. D., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0282 · Cited by 28
“tissue degeneration associated with aging (28): deletion of p16 in a genetic model of premature aging results in attenuated phenotype and extended lifespan (29), and caloric restriction that retards aging phenotypes in experimental models also attenuates the accumulation of p16positive cells (16).”
ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation
Kobayashi, T., Wang, J., Al‐Ahmadie, H. A., & Abate-Shen, C. T. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0207 · Cited by 31
Papaconstantinou, J., Wang, C. Z., Zhang, M., Yang, S. F., DeFord, J. H., Bulavin, D. V., & Ansari, N. H. (2015) · Aging · doi:10.18632/aging.100802 · Cited by 29
“Expression of the p19 gene is associated with agerelated irreversible growth arrest, and its expression is elevated in aging cells in vivo as well as in culture [39, 50, 51].”
BackgroundChen, J., Tarry‐Adkins, J. L., Heppolette, C. A. A., Palmer, D. B., & Ozanne, S. E. (2009) · Clinical Science · doi:10.1042/cs20090429 · Cited by 30
The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment
Lee, C. W., Baek, J., & Han, S. (2017) · Molecules · doi:10.3390/molecules22091411 · Cited by 31
“Cellular senescence is also thought to play a role in pathological processes, including liver fibrosis [44], renal fibrosis [45], cardiac fibrosis [46], vascular diseases (atherosclerosis) [47,48], metabolic diseases (obesity [49], type 2 diabetes [50]), neurological disorders (Alzheimer’s disease [51], Parkinson’s di…”
BackgroundLouhelainen, M., Merasto, S., Finckenberg, P., Vahtola, E., Kaheinen, P., Leskinen, H. K., Levijoki, J. M., Pollesello, P., Haikala, H. M., & Mervaala, E. M. A. (2009) · PubMed · Cited by 31
Molecular constraints of sarcopenia in the ageing muscle
Damanti, S., Senini, E., LORENZO, R. D., Merolla, A., Santoro, S., Festorazzi, C., Messina, M., Vitali, G., Sciorati, C., Manfredi, A. A., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1588014 · Cited by 36
Aziz, K., Sieben, C. J., Jeganathan, K. B., Hamada, M., Davies, B. A., Velasco, R. O. F., Rahman, N., Katzmann, D. J., & van Deursen, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120316 · Cited by 32
“BubR1H/H mice age prematurely, showing increased incidence of kyphosis, cataracts, and other progeroid phenotypes observed in MVA syndrome, such as growth retardation, muscle wasting, cardiac defects, and facial dysmorphisms (8, 10).”
BackgroundSelf-citationRack1 is essential for corticogenesis by preventing p21-dependent senescence in neural stem cells
Zhu, Q., Chen, L., Li, Y., Huang, M.-H., Shao, J., Li, S., Cheng, J., Yang, H., Wu, Y., Zhang, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109639 · Cited by 29
The dual role of cellular senescence in human tumor progression and therapy
Ma, L., Yu, J., Fu, Y., He, X., Ge, S., Jia, R., Zhuang, A., Yang, Z. H., & Fan, X. (2024) · MedComm · doi:10.1002/mco2.695 · Cited by 33
“7 In the same year, Deursen discovered p16lnk, a key gene that promotes cellular senescence, 8 and verified its expression in collaboration with Professor James Kirkland in 2011.”
BackgroundImpairment Mechanisms and Intervention Approaches for Aged Human Neuromuscular Junctions
Badawi, Y., & Nishimune, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.568426 · Cited by 30
“These mice show a decrease in muscle fiber diameter in gastrocnemius, paraspinal, and abdominal muscles, with increased intermuscular fibrosis, and impaired regenerative capacity (Baker et al., 2008; Wijshake et al., 2012).”
BackgroundInfluentialFang, M., Wang, J., Li, S., & Guo, Y. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12499 · Cited by 28
Dynamic involvement of ATG5 in cellular stress responses
Lin, H., Lin, S.-M., Chung, Y., Vonderfecht, S. L., Camden, J. M., Flodby, P., Borok, Z., Limesand, K. H., Mizushima, N., & Ann, D. K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.428 · Cited by 30
Mesenchymal Stem Cell Behavior under Microgravity: From Stress Response to a Premature Senescence
Pala, R., Cruciani, S., Manca, A., Garroni, G., Faqir, M. A. E., Lentini, V., Capobianco, G., Pantaleo, A., & Maioli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097753 · Cited by 29
“Inactivation of p19Arf accelerates sarcopenia and fat loss, suggesting that its induction suppresses cellular stress that places cells in a state of senescence [38].”
Backgroundp31comet Induces Cellular Senescence through p21 Accumulation and Mad2 Disruption
Yun, M., Han, Y.-H., Yoon, S. H., Kim, H. Y., Kim, B., Ju, Y.-J., Kang, C., Jang, S. H., Chung, H. Y., Lee, S., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0056 · Cited by 30
“The reduced amounts of the BubR1 protein result in the early onset of cellular senescence and accelerate the aging process of mice (15, 16).”
BackgroundGraves, S. I., Meyer, C. F., Jeganathan, K. B., & Baker, D. J. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.020 · Cited by 27
Self-citationMolecular evidence of senescence in corneal endothelial cells of senescence-accelerated mice.
Xiao, X., Wang, Y., Gong, H., Chen, P., & Xie, L. (2009) · PubMed Central · Cited by 25
Senotherapeutics in Cancer and HIV
Sánchez-Díaz, L., Espinosa-Sánchez, A., Blanco, J. R., & Carnero, A. (2022) · Cells · doi:10.3390/cells11071222 · Cited by 29
Dhokia, V., Albati, A., Smith, H., Thomas, G., & Macip, S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231066 · Cited by 26
The role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology update
He, S., Li, Y., Yuan, C., Li, W., Tian, W., Chen, S., Li, N., Wu, M., & Jiang, J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176961 · Cited by 25
Shining the Light on Senescence Associated LncRNAs
Ghanam, A. R., Xu, Q., Ke, S., Azhar, M., Cheng, Q., & Song, X. (2017) · Aging and Disease · doi:10.14336/ad.2016.0810 · Cited by 25
“Senescent cells acquire the characteristics that may compromise normal tissue functions, and their accumulation in the later life might lead to organismal aging and engage to the appearance of age-related pathologies as atherosclerosis [4, 13].”
The impact of mRNA turnover and translation on age-related muscle loss
Ma, J. F., Hall, D. T., & Gallouzi, I. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.05.004 · Cited by 24
FBXW7 inactivation induces cellular senescence via accumulation of p53
Gong, L., Cui, D., Liu, D., Shen, X. Z., Pan, H., Xiong, X., & Zhao, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05229-2 · Cited by 22
“The physiological relevance of cellular senescence is not limited to tumor suppression, but also includes many biological processes, such as embryonic development [45, 46], wound healing [47, 48], tissue repair [49], organismal aging [50], and various endocrine diseases [51].”
BackgroundAgarwal, P., Kabir, F. M. L., DeInnocentes, P., & Curtis, R. (2012) · InTech eBooks · doi:10.5772/27882 · Cited by 32
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Autophagy and senescence, converging roles in pathophysiology as seen through mouse models
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.001 · Cited by 20
Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma
Hsieh, P.-C., Chen, Y.-K., Tsai, K., Shieh, T., Chang, Y., Chang, J., Wu, H., & Lin, S. (2009) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.08.014 · Cited by 21
Senolytic Prodrugs: A Promising Approach to Enhancing Senescence‐Targeting Intervention
Chang, M., Dong, Y., Cruickshank‐Taylor, A. B., Gnawali, G. R., Bi, F., & Wang, W. (2024) · ChemBioChem · doi:10.1002/cbic.202400355 · Cited by 23
Guo, G., Watterson, S., Zhang, S., Bjourson, A. J., McGilligan, V., Peace, A. J., & Singh, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101363 · Cited by 25
“Inactivation of p16 has been demonstrated to delay onset of age-related symptoms in sarcopenia, coronary artery disease (CAD) and osteoarthritis (Baker et al., 2008; Bussian et al., 2018; Sousa-Victor et al., 2014).”
BackgroundSumoylation in Cellular Senescence and Aging
Gong, L., Sun, Q., & Li, D. (2017) · Current Molecular Medicine · doi:10.2174/1566524016666161223104915 · Cited by 19
Quantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 22
BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer
Weaver, R. L., Limzerwala, J. F., Naylor, R. M., Jeganathan, K. B., Baker, D. J., & van Deursen, J. M. (2016) · eLife · doi:10.7554/elife.16620 · Cited by 25
“Interphase FISH analysis on single cells isolated from various fresh tissues from 3-mo-old mice and KrasLA1 hyperplastic lungs was performed as described previously (Baker et al., 2008), and were analyzed in the Mayo Clinic Cytogenetics Core Facility.”
MethodSelf-citationVenkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
The role of VEGF in vascular dementia: impact of aging and cellular senescence
Agrawal, N., Afzal, M., Khan, N. H., Ganesan, S., Kumari, M., Sunitha, S., Dash, A., Goyal, K., Kushwaha, B., Rekha, A., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10219-w · Cited by 22
“This was observed alongside indicators indicating senescence in CECs (Baker et al. 2004, 2008; Yamazaki et al. 2016).”
Sumoylated BubR1 plays an important role in chromosome segregation and mitotic timing
Yang, F., Huang, Y., & Dai, W. H. (2012) · Cell Cycle · doi:10.4161/cc.11.4.19307 · Cited by 20
Aging and neoteny in the B lineage
Melamed, D., & Scott, D. W. (2012) · Blood · doi:10.1182/blood-2012-07-444711 · Cited by 21
The Role of Sumoylation in Senescence
Scurr, L. L., Haferkamp, S., & Rizos, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_13 · Cited by 22
“Recent evidence in mice that express low amounts of the mitotic checkpoint protein BubR1 and develop age-related phenotypes at an early age indicated that inactivation of p16 INK4a attenuated the development of age-related pathologies and decreased the expression of senescence-associated proteins ( Baker et al., 2008…”
BackgroundKyuragi, R., Matsumoto, T., Harada, Y., Saito, S., Onimaru, M., Nakatsu, Y., Tsuzuki, T., Nomura, M., Yonemitsu, Y., & Maehara, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304737 · Cited by 19
“Tissues in BubR1 hypomorphic mice, including skeletal muscle, adipose, and eye, are reported to have much higher levels of p16 compared with those in BubR1 mice, but there are no significant differences in p16 expression levels in other tissues, including the aorta.(20) Similar to this previous report, we found no sig…”
ResultThe Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis
Valenzuela, C. A., Quintanilla, R., Moore‐Carrasco, R., & Brown, N. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00188 · Cited by 18
“Accordingly, the levels of p16INK4A correlate with the aging of numerous tissues from mice and humans (89, 90).”
BackgroundA novel in vitro model of sarcopenia using BubR1 hypomorphic C2C12 myoblasts
Nozaki, T., Nikai, S., Okabe, R., Nagahama, K., & Eto, N. (2015) · Cytotechnology · doi:10.1007/s10616-015-9920-7 · Cited by 18
“but expressed high levels of several senescenceassociated genes and lost proliferative potential (Baker et al. 2008) (Table 2: age related phenotypes).”
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Therapy-induced normal tissue damage promotes breast cancer metastasis
Perkins, D. W., Steiner, I., Haider, S., Robertson, D. M., Buus, R., O’Leary, L., & Isacke, C. M. (2023) · iScience · doi:10.1016/j.isci.2023.108503 · Cited by 21
“One feature of ageing tissues is the accumulation of senescent cells (Baker et al., 2016; Baker et al., 2008), which”
BackgroundReprogramming to pluripotency can conceal somatic cell chromosomal instability
Hamada, M., Malureanu, L. A., Wijshake, T., Zhou, W., & van Deursen, J. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002913 · Cited by 16
“The finding that ES-like colonies developed from BubR1 MEFs with normal efficiency was somewhat unexpected because p19, p16 and p53 are elevated in P5 BubR1 MEFs [25,27] and have previously been shown to impair reprogramming [7,28].”
BackgroundMethodElimination of Senescent Cells: Prospects According to the Subtelomere-Telomere Theory
Libertini, G., Ferrara, N., Rengo, G., & Corbi, G. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120064 · Cited by 19
Homologous recombination-mediated irreversible genome damage underlies telomere-induced senescence
Ghadaouia, S., Olivier, M., Martinez, A., Kientega, T., Jian, Q., Lambert-Lanteigne, P., Cardin, G. B., Autexier, C., Malaquin, N., & Rodier, F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab965 · Cited by 19
Succoio, M., Comegna, M., DˈAmbrosio, C., Scaloni, A., Cimino, F., & Faraonio, R. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.07.010 · Cited by 17
Aging of the Liver: What This Means for Patients with HIV
Chan, A. W., Patel, Y. A., & Choi, S. S. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0332-x · Cited by 16
Synergistic Anti-Ageing through Senescent Cells Specific Reprogramming
Chen, R., & Skutella, T. (2022) · Cells · doi:10.3390/cells11050830 · Cited by 16
“Mice with low levels of cell cycle checkpoint kinase BubR1 expression suffer from an acceleration in ageing as well as high levels of p16INK4A in tissues with age-related histopathology [58].”
BackgroundInfluentialHu, M., Liu, Q., Song, P., Zhan, X., Luo, M., LIU, C., Yang, D., Cai, Y., Zhang, F., Jiang, F., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2117 · Cited by 17
“Furthermore, haplo-insufficiency of BubR1 in mice can trigger tumorigenesis and senescence (16,17).”
Senescent macrophages in tumor: phenotypes, roles, and interventions
Shen, W., Huang, Y., Yang, X., Zhang, Y., Pan, Y., Xiao, Y., Wang, J., Wang, C., Mao, W., & Zhao, A. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08000-5 · Cited by 17
“In vivo studies, p16Ink4a knockout mice (p16-KO) are often used to analyze senescence-related signals, but p16 de fi ciency limits the normal occurrence of aging and affects functional studies [172].”
Mosaic variegated aneuploidy in development, ageing and cancer
Malumbres, M., & Villarroya‐Beltri, C. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00762-6 · Cited by 17
“Previous studies identified a role for BUBR1 in glucose and insulin sensitivity 142 and found MAD1 and BUBR1 as partners of insulin receptor and clathrin-related assembly polypeptide 2 (AP2) subunits 143 .”
Montano, M. A., Bhasin, S., D’Aquila, R. T., Erlandson, K. M., Evans, W. J., Funderburg, N., Justice, A. C., Ndhlovu, L. C., Ojikutu, B. O., Pahor, M., et al. (2019) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2019.0130 · Cited by 14
Peeper, D. S. (2011) · Nature · doi:10.1038/479186a · Cited by 14
Zhou, D., Yin, D., Xiao, F., & Hao, J. (2015) · Medical Science Monitor · doi:10.12659/msm.895596 · Cited by 14
“Consistent with our hypothesis, a positive association between accelerated senescence and cataract formation was identified in BubR1 hypomorphic mice and discard of p16Ink4a, which may significantly postpone the appearance of cataracts in mice [21,22].”
Zhang, K., Chen, C., Liu, Y., Chen, H., & Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12328 · Cited by 16
The Emerging Role of p21 in Diabetes and Related Metabolic Disorders
ElMitwalli, O. S., Darwish, R., Al-Jabery, L., Algahiny, A. T., Roy, S., Butler, A. E., & Hasan, A. S. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313209 · Cited by 18
Insights into Muscle Degeneration from Heritable Inclusion Body Myopathies
Krause, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00013 · Cited by 13
“Recent evidence demonstrated a close link between cellular senescence and age-dependent tissue deterioration (Baker et al., 2008).”
Florido, R., Tchkonia, T., & Kirkland, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00005-1 · Cited by 17
Ikawa‐Yoshida, A., Matsumoto, T., Okano, S., Aoyagi, Y., Matsubara, Y., Furuyama, T., Nakatsu, Y., Tsuzuki, T., Onimaru, M., Ohkusa, T., et al. (2016) · Scientific Reports · doi:10.1038/srep32399 · Cited by 15
Spindle Checkpoint Regulators in Insulin Signaling
Choi, E., & Yu, H. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00161 · Cited by 13
Zhang, Y., Shao, C., Li, H., Wu, K., Gong, L., Zheng, Q., Dan, J., Jia, S., Tang, X., Wu, X., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.597566 · Cited by 15
“These data are consistent with the previous finding for the opposing role of p19 or p16 in BubR1-deficient mice, suggesting a similar function of p21 and p19 in modulating the aging process (Baker et al., 2008).”
BackgroundResultLouhelainen, M., Merasto, S., Finckenberg, P., Vahtola, E., Kaheinen, P., Levijoki, J. M., & Mervaala, E. M. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00680.x · Cited by 14
“Interestingly, oral OR-1896 treatment was able to completely normalize mRNA expression of both p19ARF and p16INK4A, and also E2F-5.”
BackgroundInfluentialTranslation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models
Inci, N., Kamali, D., Akyildiz, E. O., Tahir Turanli, E., & Bozaykut, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.828058 · Cited by 13
“Studies showed that decreased BubR1 expression causes CS through upregulation of the cell cycle inhibitor p16INK4A (Baker et al., 2004, 2008, 2011; Matsumoto et al., 2007; Kyuragi et al., 2015).”
BackgroundValidation of signalling pathways: Case study of the p16-mediated pathway
Akçay, N. İ., Bashirov, R., & Tüzmen, Ş. (2014) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720015500079 · Cited by 15
“Mutated p16 gene looses its gatekeeper role at G1 phase which might cause uncontrolled cell division leading to cancer.(8) When p16 is mutated, p21 takes responsibility for controlling its functions in G1/S checkpoint.”
BackgroundBaruah, P. S., Beauchemin, M., Hébert, J., & Bertrand, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159091 · Cited by 15
“Reduced BubR1 expression in mouse embryonic fibroblasts causes increased aneuploidy and senescence, an effect associated with opposing roles of p16/INK4A and p19/Arf controlling senescence and aging [48, 49].”
BackgroundLee, J. S., Lee, C. G., Lee, K. W., & Lee, C. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.12.093 · Cited by 11
“Mutant mice with low levels of BubR1 develop features of age-related diseases, such as cachectic dwarfism, sarcopaenia, cataracts, lordokyphosis, and impaired wound healing (Baker et al., 2004; 2008).”
BackgroundResultInfluentialNatural Products in Aging: Cellular Mechanisms and Emerging Therapeutics for Age‐Related Disorders
Dixit, V., Chaubey, K. K., Dayal, D., Chole, P. B., Manjunath, B. T., Bachheti, R. K., Gupta, P. C., Bachheti, A., & Worku, L. A. (2025) · Journal of Aging Research · doi:10.1155/jare/6868732 · Cited by 12
“Deactivation of p16INK4a stops synthesizing senescent cells and reduces the synthesis of aging phenotypes like cataracts, lipodystrophy, and sar-copenia [61].”
Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission
Liao, K.-M., Chen, C., Luo, W., Hsu, C.-W., Yu, S., Yang, P., & Su, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114616 · Cited by 11
IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf- Dependent
Page, A., Bravo, A., Suárez-Cabrera, C., Alameda, J. P., Casanova, M. L., Lorz, C., Segrelles, C., Segovia, J. C., Paramio, J. M., Navarro, M., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0157 · Cited by 12
“Although some of the activities of p16 and p19 proteins are different, and even opposite (46), both of themhave strong andnonredundant tumor suppressor activity.”
BackgroundThe ING1a model of rapid cell senescence
Bertschmann, J., Thalappilly, S., & Riabowol, K. T. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.06.004 · Cited by 14
New Insights into Chronological Mobility of Retrotransposons In Vivo
Ghanam, A. R., Cao, J., Ouyang, X., & Song, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2818415 · Cited by 10
Targeting immunosenesence promotes clearance of senescent cells
Tizazu, A. M., Tessema, E. A., & Cexus, O. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00518-8 · Cited by 15
“This contrasting role can be explained by antagonistic pleiotropic effects which suggest genes that are beneficial at a young age can be traded off for aging [11, 12], and help us to understand many of the features that link cancer and senescence.”
A defective splicing machinery promotes senescence through MDM4 alternative splicing
Deschênes, M., Durand, M., Olivier, M., Pellerin‐Viger, A., Rodier, F., & Chabot, B. (2024) · Aging Cell · doi:10.1111/acel.14301 · Cited by 11
“Given the role of senescent cell accumulation in physiological aging (Baker et al., 2008, 2011, 2016) and that splicing defects, including increased intron retention, are also established phenotypes of aging (Bhadra et al., 2020; Deschênes & Chabot, 2017), it is possible that defective splicing…”
BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer
Pun, R., Kumari, N., Monieb, R. H., Wagh, S., & North, B. J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.005 · Cited by 10
Демура, Т. А., Revazova, Z. V., Коган, Е. А., & Adamyan, L. V. (2017) · Russian Journal of Archive of Pathology · doi:10.17116/patol201779319-26 · Cited by 10
Baramiya, M. G., & Baranov, E. (2020) · Future Science OA · doi:10.2144/fsoa-2019-0119 · Cited by 12
“All these evidences support p16INK4a involvement in senescence and age-related pathologies [20].”
BackgroundSenescent cells in the development of cardiometabolic disease
Postmus, A. C., Sturmlechner, I., Jonker, J. W., van Deursen, J. M., van de Sluis, B., & Kruit, J. K. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000602 · Cited by 10
Matsubayashi, S., Ito, S., Araya, J., & Kuwano, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1079626 · Cited by 15
Storozynsky, Q. T., Han, X., Komant, S. J., Agopsowicz, K. C., Potts, K. G., Gamper, A. M., Godbout, R., Evans, D. H., & Hitt, M. (2023) · Cancers · doi:10.3390/cancers15133341 · Cited by 9
“Further, senescent cells are implicated in a spectrum of biological processes including developmental activities [72], tissue repair [73,74], inflammation and alerting host immunological systems [75–77], age-related pathology [78,79], and cancer [80].”
BackgroundCaloric Restriction Improves Spatial Learning Deficits in Tau Mice
Cogut, V., McNeely, T. L., Bussian, T. J., Graves, S. I., & Baker, D. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231117 · Cited by 10
“Primers used to amplify Gfap , S100b , Pai1 , Il1b , p21 , p16 , p19 and Tbp were as previously described [22–24].”
Self-citationAging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 11
Multiwalled Carbon Nanotubes Induce Fibrosis and Telomere Length Alterations
Alswady‐Hoff, M., Erdem, J. S., Aleksandersen, M., Anmarkrud, K. H., Skare, Ø., Lin, F. ‐., Simensen, V., Arnoldussen, Y. J., Skaug, V., Ropstad, E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116005 · Cited by 9
“An upregulation in CDKN2A is a classical feature of cellular senescence [42].”
BackgroundChromosome Instability ( CIN ), Aneuploidy and Cancer
Yuen, K. W. Y. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022413 · Cited by 9
Lee, J., Han, M., Wang, K., Butler, L. R., & Sinclair, D. A. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101442 · Cited by 9
Akçay, N. İ., & Bashirov, R. (2021) · Biosystems · doi:10.1016/j.biosystems.2021.104562 · Cited by 8
Gupta, K. P., Dholaniya, P. S., Chekuri, A., & Kondapi, A. K. (2015) · AGE · doi:10.1007/s11357-015-9789-6 · Cited by 9
Cheng, Y. (2012) · InTech eBooks · doi:10.5772/1337 · Cited by 10
Lopes, L. O., Cury, S. S., de Moraes, D., Oliveira, J. S., de Oliveira, G., Cabral-Marques, O., Fernández, G. J., Hirata, M. H., Wang, D., Dal‐Pai‐Silva, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031777 · Cited by 7
The insulin receptor endocytosis
Wu, J., Park, S. H., & Choi, E. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.020 · Cited by 8
Expansion of senescent megakaryocyte-lineage cells maintains CML cell leukemogenesis
Tanabe, Y., Kawamoto, S., Takaku, T., Morishita, S., Hirao, A., Komatsu, N., Hara, E., Mukaida, N., & Baba, T. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003117 · Cited by 10
Takeshita, H., Yamamoto, K. I., Mogi, M., Wang, Y., Nozato, Y., Fujimoto, T., Yokoyama, S., Hongyo, K., Nakagami, F., Akasaka, H., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.021030 · Cited by 6
Perspectives on cellular senescence and short term dietary restriction in adults
Kirkland, J. L. (2010) · Aging · doi:10.18632/aging.100247 · Cited by 7
Local and systemic impact of adipocyte senescence-associated secretory profile
Wan, Y. C. E., Dufau, J., & Spalding, K. L. (2024) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2024.100547 · Cited by 9
Distinct precursor landscape of subcutaneous and visceral fat in development and aging
Lin, F., & Sul, H. S. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116706 · Cited by 9
“128 BubR1 hypomorphic mice developed a SASP phenotype in iSAT as they age, and targeted elimination of p16-positive cells rescued this phenotype.”
Increase in tumor suppressor Arf compensates gene dysregulation in in vitro aged adipocytes
Hasan, A. U., Ohmori, K., Hashimoto, T., Kamitori, K., Yamaguchi, F., Konishi, K., Noma, T., Igarashi, J., Yamashita, T., Hirano, K., et al. (2016) · Biogerontology · doi:10.1007/s10522-016-9661-9 · Cited by 7
Minoxidil Regulates Aging-Like Phenotypes in Rat Cortical Astrocytes In Vitro
Bang, M., Yang, S. J., Ahn, T., Han, S., Shin, C. Y., & Kwon, K. J. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.144 · Cited by 6
“Interestingly, removal of p16-positive 124https://doi.org/10.4062/biomolther.2022.144 cells delays the onset of aging or age-related diseases (Baker et al., 2008, 2011).”
BackgroundInfluentialDetection of Senescence Markers During Mammalian Embryonic Development
Storer, M. A., & Keyes, W. M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_19 · Cited by 6
Metadata
- Authors
- Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., Eberhardt, N. L., Terzic, A., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2008-05-30
- Volume
- 10
- Issue
- 7
- Pages
- 825-836
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC2594014
- OpenAlex
- W1982763980
- Cited by
- 408
- References
- 50
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 20 · 2022: 26 · 2021: 32 · 2020: 30 · 2019: 23 · 2018: 25 · 2017: 29 · 2016: 29 · 2015: 24 · 2014: 27 · 2013: 17 · 2012: 20
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-05-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- National Institutes of Health
- National Cancer Institute (R01CA096985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- p16INK4a, p19ARF, cellular senescence, aging, tumour suppressor, skeletal muscle, adipose tissue, premature aging, checkpoint kinase 2
- MeSH terms
- Adipose Tissue, Aging, Animals, Cells, Cultured, Eye, Fibroblasts, Genotype, Humans, Male, Mice, Inbred C57BL, Neoplasms, Tissue Distribution, Biomarkers, Survival Rate, Cellular Senescence, Protein Serine-Threonine Kinases, Mice, Knockout, Muscle, Skeletal, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.